Moleculin Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Moleculin Biotech has a total shareholder equity of $26.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $38.2M and $12.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$23.55m |
Equity | US$26.07m |
Total liabilities | US$12.14m |
Total assets | US$38.22m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MOL's short term assets ($26.3M) exceed its short term liabilities ($6.8M).
Long Term Liabilities: MOL's short term assets ($26.3M) exceed its long term liabilities ($5.3M).
Debt to Equity History and Analysis
Debt Level: MOL is debt free.
Reducing Debt: MOL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MOL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: MOL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.2% each year